by | Feb 23, 2021 | News
There are currently more than 150 different COVID-19 vaccines under development. Of these, more than 50 have reached human trials, and several have been approved for emergency or full use on six continents. In the US, two vaccines—one from the biotechnology company,...
by | Feb 23, 2021 | News
The coronavirus disease (COVID-19) pandemic has changed the ways clinical trials are administered, said Reynold Panettieri, vice chancellor for Translational Medicine and Science at Rutgers. “In the past, clinical trials and clinical research were done usually in a...
by | Feb 23, 2021 | News
By now, you’ve probably already seen the reports on the emergence of new, more contagious variants of SARS-CoV-2, the virus that causes COVID-19. And, like me, you’ve probably stared at the ceiling after reading them, asking, “Really, universe? Really?” As...
by | Feb 23, 2021 | News
Please read Dr. Crystal’s article in Innovation in Aging titled, “National Partnership to Improve Dementia Care in Nursing Homes Campaign: State and Facility Strategies, Impact, and Antipsychotic Reduction Outcomes”. Antipsychotic medications have...
by | Feb 23, 2021 | News
The COVID-19 vaccination rollout is underway in New Jersey. However, residents still have many public health questions — on the efficacy of double masking, mRNA and vaccine safety for pregnant women, to new variant strains of COVID-19. Rutgers University...
